" class="no-js "lang="en-US"> Biopharma Archives - Medtech Alert
Tuesday, April 23, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Reata Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President, Chief Research & Development Officer

Reata Pharmaceuticals, a global biopharmaceutical company focused on developing and commercializing novel therapies for patients […]

HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease

HanAll Biopharma and Daewoong Pharmaceutical announced that they have entered into a co-development agreement with NurrOn […]

CPC Launches Biopharma's Largest Aseptic Connectors, AseptiQuik W Series

CPC (Colder Products Company), part of Dover and a leading manufacturer of connection technologies used […]

PharmaVentures Establishes an Office in Seoul to Enhance Access for South Korean Biotechs

PharmaVentures announces its new office in South Korea as part of its continued strategic expansion. […]

Neochromosome and Sumitovant Biopharma Announce Successful Collaboration to Accelerate Protein Drug Discovery and Improve Manufacturing

Neochromosome, a wholly owned subsidiary of Opentrons Labworks, focused on changing the world of biologics […]

Asieris Appoints Dr. Linda Wu as Chief Development Officer

Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for […]

BioSpace Names Most Promising New Biopharma Companies to Watch in 2023

BioSpace, the leading life sciences news and careers site, has announced its 2023 selections for […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more